Grants and Contributions:
Title:
Biomarker Discovery and Validation for Improvement of PolypDx™
Agreement Number:
985822
Agreement Value:
$356,490.00
Agreement Date:
Jan 1, 2022 - May 31, 2024
Description:
This project seeks to identify and validate additional urinary biomarkers for colorectal cancer and precancerous polyps to improve the performance of a colorectal cancer screening test.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T6N 1H1
Reference Number:
172-2021-2022-Q4-985822
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
850007709
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 121 days. The total amended value is 43,290 dollars.
Amendment Date
Dec 7, 2023
Recipient's Legal Name:
Metabolomic Technologies Inc.
Federal Riding Name:
Edmonton Mill Woods
Federal Riding Number:
48017
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: